Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [2];  [2];  [1]
  1. Univ. of Pennsylvania, Philadelphia, PA (United States)
  2. Columbia Univ., New York, NY (United States)
Histone deacetylases (HDACs) regulate myriad cellular processes by catalyzing the hydrolysis of acetyl–L-lysine residues in histone and nonhistone proteins. The Zn2+-dependent class IIb enzyme HDAC6 regulates microtubule function by deacetylating α-tubulin, which suppresses microtubule dynamics and leads to cell cycle arrest and apoptosis. Accordingly, HDAC6 is a target for the development of selective inhibitors that might be useful in new therapeutic approaches for the treatment of cancer, neurodegenerative diseases, and other disorders. Here, we present high-resolution structures of catalytic domain 2 from Danio rerio HDAC6 (henceforth simply “HDAC6”) complexed with compounds that selectively inhibit HDAC6 while maintaining nanomolar inhibitory potency: N-hydroxy-4-[(N(2-hydroxyethyl)-2-phenylacetamido)methyl)-benzamide)] (HPB), ACY-1215 (Ricolinostat), and ACY-1083. These structures reveal that an unusual monodentate Zn2+ coordination mode is exploited by sterically bulky HDAC6-selective phenylhydroxamate inhibitors. We additionally report the ultrahigh-resolution structure of the HDAC6–trichostatin A complex, which reveals two Zn2+-binding conformers for the inhibitor: a major conformer (70%) with canonical bidentate hydroxamate-Zn2+ coordination geometry and a minor conformer (30%) with monodentate hydroxamate-Zn2+ coordination geometry, reflecting a free energy difference of only 0.5 kcal/mol. The minor conformer is not visible in lower resolution structure determinations. As a result, structural comparisons of HDAC6-inhibitor complexes with class I HDACs suggest active site features that contribute to the isozyme selectivity observed in biochemical assays.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
NIH; USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22). Scientific User Facilities Division; USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23)
Grant/Contract Number:
AC02-05CH11231; AC02-06CH11357; AC02-76SF00515
OSTI ID:
1426287
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 51 Vol. 114; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (51)

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget? journal November 2015
Development and therapeutic impact of HDAC6-selective inhibitors journal September 2012
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides journal May 2010
Molecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase journal June 2014
Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic Analysis journal April 2004
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes journal December 2011
General Base–General Acid Catalysis in Human Histone Deacetylase 8 journal January 2016
Metal-dependent Deacetylases: Cancer and Epigenetic Regulators journal February 2016
Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis journal November 1981
Catalytic Activity and Inhibition of Human Histone Deacetylase 8 Is Dependent on the Identity of the Active Site Metal Ion journal May 2006
Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors , journal December 2008
Kinetics and Equilibria of Cis/Trans Isomerization of Backbone Amide Bonds in Peptoids journal October 2007
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A journal August 2010
Novel Binding Mode of Hydroxamate Inhibitors to Human Carbonic Anhydrase II journal January 1997
Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth journal October 2012
Structure of a unique binuclear manganese cluster in arginase journal October 1996
HDAC6 is a microtubule-associated deacetylase journal May 2002
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors journal September 1999
Structure of HDAC3 bound to co-repressor and inositol tetraphosphate journal January 2012
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition journal July 2016
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition journal July 2016
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates journal April 2016
Epigenetic protein families: a new frontier for drug discovery journal April 2012
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders journal August 2014
The growing landscape of lysine acetylation links metabolism and cell signalling journal July 2014
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex journal August 2007
Histone deacetylases (HDACs): characterization of the classical HDAC family journal March 2003
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation journal April 2003
Development of a histone deacetylase 6 inhibitor and its biological effects journal September 2013
Creation of a histone deacetylase 6 inhibitor and its biological effects journal September 2015
Acetylation and Methylation of Histones and Their Possible role in the Regulation of rna Synthesis journal May 1964
Three proteins define a class of human histone deacetylases related to yeast Hda1p journal April 1999
Identification of a New Family of Higher Eukaryotic Histone Deacetylases: COORDINATE EXPRESSION OF DIFFERENTIATION-DEPENDENT CHROMATIN MODIFIERS journal January 1999
Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations journal December 2009
Role of the Tetradecapeptide Repeat Domain of Human Histone Deacetylase 6 in Cytoplasmic Retention journal September 2004
Structural Basis for Sirtuin Activity and Inhibition journal October 2012
Acetylation: a regulatory modification to rival phosphorylation? journal March 2000
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations journal December 2014
HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy journal January 2017
Structure and mechanism of non-histone protein acetyltransferase enzymes journal June 2013
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions journal July 2009
Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux journal February 2010
Regulation of Cellular Metabolism by Protein Lysine Acetylation journal February 2010
Histone deacetylases in memory and cognition journal December 2014
Acetylation of Histones and Transcription-Related Factors journal June 2000
Histone Deacetylase Inhibitors: Overview and Perspectives journal October 2007
New and emerging HDAC inhibitors for cancer treatment journal January 2014
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma journal March 2012
Selective Histone Deacetylase Inhibitors with Anticancer Activity journal October 2015
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration journal January 2016
Histone deacetylase 6 in health and disease journal February 2015

Cited By (12)

Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-β probes journal September 2019
HDAC6—An Emerging Target Against Chronic Myeloid Leukemia? journal January 2020
Anticancer Ruthenium Complexes with HDAC Isoform Selectivity journal May 2020
A highly HDAC6-selective inhibitor acts as a fluorescent probe journal January 2018
A selenium-containing selective histone deacetylase 6 inhibitor for targeted in vivo breast tumor imaging and therapy journal January 2019
Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6 journal February 2019
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019) journal December 2019
Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present) journal February 2020
HDAC6 as a potential therapeutic target for peripheral nerve disorders journal October 2018
Ronald Charles David Breslow. 14 March 1931—25 October 2017 journal January 2019
Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6 text January 2019
Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6 text January 2019

Similar Records

A Novel Zinc Binding Group for HDAC6 Inhibition
Journal Article · Thu May 12 20:00:00 EDT 2022 · FASEB Journal · OSTI ID:1867749

Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity
Journal Article · Thu Aug 16 20:00:00 EDT 2018 · Journal of Medicinal Chemistry · OSTI ID:1476085